The Medical Journey and Contributions of Prof. Mikhail Blagosklonny

Prof. Mikhail Blagosklonny has a few decades of experience under his belt. He has received his education from some of the leading Russian institutions and has done research in some of the biggest research centers in the United States of America. Prof. Mikhail Blagosklonny has also contributed through his works as an editor and a writer.

Born in Russia, Prof. Mikhail Blagosklonny spent his early life in his home country. He received his higher education from some of the renowned institutions of Russia such as the First Pavlov State Medical University. Prof. Mikhail Blagosklonny graduated from First Pavlov with a major in Experimental Medicine as well as Cardiology. After earning his Ph. D., Prof. Mikhail Blagosklonny also pursued an M. D. in Internal Medicine from the First Pavlov State Medical University.

Read more: http://www.aging-us.com/article/100591/text

Upon finishing his studies, Prof. Mikhail Blagosklonny moved to the United States of America in order to join a team of experts and embark n his career in the medical field. He moved to New York City where he started teaching oncology at the New York Medical College in 2002 as well as doing some medical research on the side. He was at the post of associate professor of medicine for a handful of years. After that, Prof. Mikhail Blagosklonny became a member of another institution where he could conduct further medical research – the Ordway Research Institute. That institution was a good fit for Prof. Mikhail Blagosklonny for a handful of years, but he wanted to continue his research in more detail in the field of cancer as oncology was one of the two primary fields in which

Prof. Mikhail Blagosklonny had specialized. Prof. Mikhail Blagosklonny could not narrow down his research at the Ordway Research Center, and so he moved on to become a part of the Roswell Park Cancer Institute in the year of 2009. Prof. Mikhail Blagosklonny is still working there.

As a part of the Roswell Park Cancer Institute, Prof. Mikhail Blagosklonny has been able to focus on his research and conduct his studies more in detail. He has also been able to work in the field of biogerontology as Prof. Mikhail Blagosklonny is deeply dedicated to his studies of aging and is determined to find solutions that would slow down the process.

Medical research has not been the only thing that Prof. Mikhail Blagosklonny is dedicated to. He has written and published over one hundred medical papers over the course of his career. Not only that, but Prof. Mikhail Blagosklonny is also one of the two editors in chief of a rising medical journal which is called Oncotarget. The other chief editor is a colleague of Prof. Mikhail Blagosklonny. While the medical journal of Oncotarget is the first journal that Prof. Mikhail Blagosklonny is improving, there are two more medical journals that he edits. There is also the journal called Cell Cycle which published the latest research on aging and biogerontology as a whole. The other journal is called Aging as that is its subject as well.

Prof. Mikhail Blagosklonny has a few decades of experience under his belt. He has received hs education from some of the leading Russian institutions and has done research in some of the biggest research centers in the United States of America. Prof. Mikhail Blagosklonny has also contributed through his works as an editor and a writer. Visit classroomvoices.org to read more about Mikhail.

Born in Russia, Prof. Mikhail Blagosklonny spent his early life in his home country. He received his higher education from some of the renowned institutions of Russia such as the First Pavlov State Medical University. Prof. Mikhail Blagosklonny graduated from First Pavlov wth a major in Experimental Medicine as well as Cardiology. After earning his Ph. D., Prof. Mikhail Blagosklonny also pursued an M. D. in Internal Medicine from the First Pavlov State Medical University.

Upon finishing his studies, Prof. Mikhail Blagosklonny moved to the United States of America in order to join a team of experts and embark n his career in the medical field. He moved to New York City where he started teaching oncology at the New York Medical College in 2002 as well as doing some medical research on the side. He was at the post of associate professor of medicine for a handful of years. After that, Prof. Mikhail Blagosklonny became a member of another institution where he could conduct further medical research – the Ordway Research Institute. That institution was a good fit for Prof. Mikhail Blagosklonny for a handful of years, but he wanted to continue his research in more detail in the field of cancer as oncology was one of the two primary fields in which

Prof. Mikhail Blagosklonny had spesialized. Prof. Mikhail Blagosklonny could not narrow down his research at theOrdway Research Center, and so he moved on to become a part of the Roswell Park Cancer Institute in the year of 2009. Prof. Mikhail Blagosklonny is still working there.

As a part of the Roswell Park Cancer Institute, Prof. Mikhail Blagosklonny has been able to focus on his research and conduct his studies more in detail. He has also been able to work in the field of biogerontology as Prof. Mikhail Blagosklonny is deeply dedicated to his studies of aging and is determined to find solutions that would slow down the process.

Medical research has not been the only thing that Prof. Mikhail Blagosklonny is dedicated to. He has written and published over one hundred medical papers over the course of his career. Not only that, but Prof. Mikhail Blagosklonny is also one of the two editors in chief of a rising medical journal which is called Oncotarget. The other chief editor is a colleague of Prof. Mikhail Blagosklonny. While the medical journal of Oncotarget is the first journal that Prof. Mikhail Blagosklonny is improving, there are two more medical journals that he edits. There is also the journal called Cell Cycle which published the latest research on aging and biogerontology as a whole. The other journal is called Aging as that is its subject as well.

Leave a Reply